Nadim Ahmed, President and CEO at Cullinan Therapeutics, Inc. (CGEM), sold 19,844 shares at $10.01 ($199K) on 2025-12-23, disclosed to the SEC on 2025-12-29.
Open-market sale of $199k CGEM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.01 | 9,922 | $99K | 50.0% |
| 2 | $10.01 | 9,922 | $99K | 50.0% |
| Total | $10.01 avg | 19,844 | $199K | 100% |
| Filing → |
| CGEM | SELL | 2025-02-27 | $214K | — | Filing → |
| CGEM | SELL | 2024-12-27 | $100K | — | Filing → |
| CGEM | SELL | 2023-12-27 | $39K | — | Filing → |